Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2007 037 903.2 |
96 | EP file number | EAKZ | 07 78 4499.1 |
86 | WO file number | WAKZ | PCT/US2007/071749 |
97 | EP publication number | EPN | 2069374 |
87 | WO publication number | WPN | 2008002824 |
54 | Designation/title | TI | KRISTALLINE SOLVATE VON (1S)-1,5-ANHYDRO-1-C-(3-((PHENYL)METHYL)PHENYL)-D-GLUCITOL-DERIVATEN MIT ALKOHOLEN ALS SGLT2-INHIBITOREN ZUR BEHANDLUNG VON DIABETES |
51 | IPC main class | ICM (ICMV) | C07H 7/04 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/70 (2006.01), A61P 3/10 (2006.01) |
22 | DE application date | DAT | Jun 21, 2007 |
96 | EP application date | EAT | Jun 21, 2007 |
86 | WO application date | WAT | Jun 21, 2007 |
43 | Date of first publication | OT | Jan 3, 2008 |
| Date of publication of grant | PET | Jul 30, 2014 |
71/73 | Applicant/owner | INH | AstraZeneca AB, Södertälje, SE |
72 | Inventor | IN | DESHPANDE, Prashant, P., New Brunswick, New Jersey 08903, US; RAMAKRISHNAN, Srividya, Milltown, NJ 08850, US; NIRSCHL, Alexandra, A., Yardley, Pennsylvania 19067, US; GOUGOUTAS, Jack, Z., Princeton, New Jersey 08540, US; LOBINGER, Hildegard, D-93059 Regensburg, DE; GROSSO, John, Anthony, New Brunswick, New Jersey 08903, US; DIMARCO, John, D., Princeton, New Jersey 08543, US; LAI, Chiajen, New Brunswick, New Jersey 08903, US; BIEN, Jeffrey, T., New Brunswick, New Jersey 08903, US; RIEBEL, Peter, D-94099 Ruhstorf A.d. Rott, DE; WANG, Chenchi, New Brunswick, New Jersey 08903, US; SINGH, Janak, Pennington, NJ 08534, US |
74 | Representative | VTR | Mewburn Ellis LLP, 80333 München, DE |
| Address for service | | Mewburn Ellis LLP, 80333 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 765481 Jun 20, 2007
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 817118 P Jun 28, 2006
|
| Due date | FT FG | Jun 30, 2026 Annual fee for the 20th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR |
81 | Designated WO countries | WDS | AL, RS, HR, BA, MK |
| Published EP/WO documents | EPWOPN | Original document:
EP000002069374 Searchable text:
EP000002069374 Original document:
EP000002069374B1 Searchable text:
EP000002069374B1 Original document:
EP000002069374B2 Searchable text:
EP000002069374B2 Original document:
WO002008002824 Searchable text:
WO002008002824 |
43 | Date of first publication | EVT | Jan 3, 2008 |
| Date of the first transfer into DPMAregister | EREGT | May 27, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Jun 3, 2025 (Show all update days)(Hide all update days)- Jun 3, 2025
- Inventor: changed
- Due date: changed
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 30.07.2014: new
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 30.07.2014: deleted
- Sep 3, 2024
- St.36: changed (technical change)
- Jul 10, 2024; Apr 10, 2024; May 3, 2023; May 7, 2022; Apr 30, 2022; Aug 12, 2021; Jul 8, 2021; Jun 3, 2021; Jun 15, 2020; Mar 6, 2020; Aug 17, 2019; Jun 26, 2019; Oct 25, 2018; Jun 21, 2018; Jul 4, 2017; Feb 16, 2017; Jun 28, 2016; Jun 30, 2015; Jun 11, 2015; Oct 18, 2014; Sep 11, 2014; Aug 6, 2014; Jul 31, 2014; Feb 12, 2013
- Historical data not available for this/these date(s)
- May 27, 2011
- Date of the first transfer into DPMAregister
|